These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21115488)

  • 1. Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeast.
    Martins IM; Cortés JC; Muñoz J; Moreno MB; Ramos M; Clemente-Ramos JA; Durán A; Ribas JC
    J Biol Chem; 2011 Feb; 286(5):3484-96. PubMed ID: 21115488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papulacandin B resistance in budding and fission yeasts: isolation and characterization of a gene involved in (1,3)beta-D-glucan synthesis in Saccharomyces cerevisiae.
    Castro C; Ribas JC; Valdivieso MH; Varona R; del Rey F; Duran A
    J Bacteriol; 1995 Oct; 177(20):5732-9. PubMed ID: 7592316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.
    Onishi J; Meinz M; Thompson J; Curotto J; Dreikorn S; Rosenbach M; Douglas C; Abruzzo G; Flattery A; Kong L; Cabello A; Vicente F; Pelaez F; Diez MT; Martin I; Bills G; Giacobbe R; Dombrowski A; Schwartz R; Morris S; Harris G; Tsipouras A; Wilson K; Kurtz MB
    Antimicrob Agents Chemother; 2000 Feb; 44(2):368-77. PubMed ID: 10639364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cps1+, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B.
    Ishiguro J; Saitou A; Durán A; Ribas JC
    J Bacteriol; 1997 Dec; 179(24):7653-62. PubMed ID: 9401022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.
    Douglas CM; D'Ippolito JA; Shei GJ; Meinz M; Onishi J; Marrinan JA; Li W; Abruzzo GK; Flattery A; Bartizal K; Mitchell A; Kurtz MB
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2471-9. PubMed ID: 9371352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Cell Wall Antifungals Reveal a Special Synergistic Activity in
    Berzaghi R; Agócs A; Curto MA; Gulyás-Fekete G; Kocsis B; Ribas JC; Lóránd T
    Front Microbiol; 2019; 10():1692. PubMed ID: 31428061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
    Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Localization of
    San-Quirico E; Curto MÁ; Gómez-Delgado L; Moreno MB; Pérez P; Ribas JC; Cortés JCG
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.
    Pfaller MA; Messer SA; Rhomberg PR; Borroto-Esoda K; Castanheira M
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
    Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.
    Hori Y; Shibuya K
    Med Mycol J; 2018; 59(2):E31-E40. PubMed ID: 29848909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of Schizosaccharomyces pombe mutants defective in cell wall (1-3)beta-D-glucan.
    Ribas JC; Diaz M; Duran A; Perez P
    J Bacteriol; 1991 Jun; 173(11):3456-62. PubMed ID: 1828464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
    Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nikkomycin Z supersensitivity of an echinocandin-resistant mutant of Saccharomyces cerevisiae.
    el-Sherbeini M; Clemas JA
    Antimicrob Agents Chemother; 1995 Jan; 39(1):200-7. PubMed ID: 7695307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase.
    Douglas CM; Marrinan JA; Li W; Kurtz MB
    J Bacteriol; 1994 Sep; 176(18):5686-96. PubMed ID: 8083161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FKS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C.
    Ohyama T; Miyakoshi S; Isono F
    Antimicrob Agents Chemother; 2004 Jan; 48(1):319-22. PubMed ID: 14693557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.
    Kurtz MB; Abruzzo G; Flattery A; Bartizal K; Marrinan JA; Li W; Milligan J; Nollstadt K; Douglas CM
    Infect Immun; 1996 Aug; 64(8):3244-51. PubMed ID: 8757860
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Nunnally NS; Etienne KA; Angulo D; Lockhart SR; Berkow EL
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinocandin Drugs Induce Differential Effects in Cytokinesis Progression and Cell Integrity.
    Yagüe N; Gómez-Delgado L; Curto MÁ; Carvalho VSD; Moreno MB; Pérez P; Ribas JC; Cortés JCG
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.